Neoadjuvant therapy for resectable pancreatic cancer

The use of neoadjuvant therapies has played a major role for borderline resectable and locally advanced pancreatic cancers(PCs). For this group of patients, preoperative chemotherapy or chemoradiation has increased the likelihood of surgery with negative resection margins and overall survival. On th...

Full description

Saved in:
Bibliographic Details
Published inWorld journal of gastrointestinal oncology Vol. 9; no. 12; pp. 457 - 465
Main Authors Rahman, Sheikh Hasibur, Urquhart, Robin, Molinari, Michele
Format Journal Article
LanguageEnglish
Published China Baishideng Publishing Group Inc 15.12.2017
Subjects
Online AccessGet full text

Cover

Loading…